Myelofibrosis is a rare form of blood cancer that causes scar tissue to build up in the bone marrow, which is the is soft, fatty tissue inside most bones that produces blood cells. Myelofibrosis can develop on its own, but in 15 to 20 percent of cases this cancer occurs as a result of other MPNs which is called secondary myelofibrosis.
Myelofibrosis is a rare disease. The incidence is estimated to be 1.5 cases per 100,000 people in the United States.
Myelofibrosis is diagnosed most often in people over age 50.
From the moment you were diagnosed with cancer, you may have been feeling hopeless and lonely. But you are not alone.
You can learn about Myelofibrosis treatment options with our free matching service, which uses artificial intelligence technology to find clinical trials of promising new therapies.
Comment on this video and subscribe to our channel!
Explore the possibilities for myelofibrosis treatment:
[ Ссылка ]
For more Oncology Information, you can visit:
[ Ссылка ]
Find more sources for oncology and join our newsletter for e-mailing:
[ Ссылка ]
You can subscribe to our channel to follow all oncology contents.
[ Ссылка ]
At Massive Bio, we believe all cancer patients deserve equal access to leading edge therapies and new-emerging clinical trials, regardless of where they live or their ability to pay.
Contact Us:
Phone: +1 844-627-7246
Email: support@massivebio.com
#Myelofibrosis #BloodCancer #MyeloproliferativeNeoplasms #MyelofibrosisTreatment #MyelofibrosisSymptoms #MyelofibrosisLifeExpectancy #IsMyelofibrosisCancerCurable #MassiveBio #CancerResearch
